All Day

Portal Therapeutics webinar

On Tuesday, June 23, Portal Therapeutics (a @GondolaBio affiliate company) is hosting an in-depth webinar reviewing the Phase 2a GATEWAY study data for PORT-77 in erythropoietic protoporphyria (EPP). For clinicians […]